HighMark Wealth Management LLC Purchases 431,200 Shares of Health Catalyst, Inc. $HCAT

HighMark Wealth Management LLC increased its holdings in Health Catalyst, Inc. (NASDAQ:HCAT) by 139.0% in the fourth quarter, Holdings Channel reports. The institutional investor owned 741,482 shares of the company’s stock after buying an additional 431,200 shares during the period. Health Catalyst makes up 0.7% of HighMark Wealth Management LLC’s holdings, making the stock its 21st largest holding. HighMark Wealth Management LLC’s holdings in Health Catalyst were worth $1,772,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in HCAT. First Light Asset Management LLC raised its position in shares of Health Catalyst by 17.2% in the second quarter. First Light Asset Management LLC now owns 12,230,181 shares of the company’s stock valued at $46,108,000 after buying an additional 1,793,374 shares in the last quarter. Millennium Management LLC raised its position in shares of Health Catalyst by 2,513.3% in the third quarter. Millennium Management LLC now owns 1,589,536 shares of the company’s stock valued at $4,530,000 after buying an additional 1,528,710 shares in the last quarter. Nepsis Inc. raised its position in shares of Health Catalyst by 26.6% in the fourth quarter. Nepsis Inc. now owns 1,915,794 shares of the company’s stock valued at $4,579,000 after buying an additional 402,762 shares in the last quarter. AMH Equity Ltd raised its position in shares of Health Catalyst by 54.5% in the third quarter. AMH Equity Ltd now owns 660,000 shares of the company’s stock valued at $1,881,000 after buying an additional 232,851 shares in the last quarter. Finally, Moore Capital Management LP raised its position in shares of Health Catalyst by 130.8% in the third quarter. Moore Capital Management LP now owns 398,857 shares of the company’s stock valued at $1,137,000 after buying an additional 226,023 shares in the last quarter. 85.00% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

HCAT has been the subject of several research analyst reports. Citigroup lowered their price objective on shares of Health Catalyst from $2.75 to $1.75 and set a “neutral” rating for the company in a research report on Friday, March 13th. Raymond James Financial set a $3.00 price objective on shares of Health Catalyst in a research report on Friday, March 13th. Stephens lowered their price objective on shares of Health Catalyst from $2.00 to $1.75 and set an “equal weight” rating for the company in a research report on Tuesday. Canaccord Genuity Group lowered their price objective on shares of Health Catalyst from $5.00 to $2.00 and set a “buy” rating for the company in a research report on Friday, March 13th. Finally, Cantor Fitzgerald restated a “neutral” rating on shares of Health Catalyst in a research report on Monday. Four analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $2.77.

Health Catalyst Price Performance

Health Catalyst stock opened at $1.34 on Thursday. The stock’s 50 day moving average is $1.35 and its 200 day moving average is $2.03. The company has a debt-to-equity ratio of 1.10, a current ratio of 1.69 and a quick ratio of 1.89. The firm has a market cap of $99.01 million, a P/E ratio of -0.36 and a beta of 1.63. Health Catalyst, Inc. has a one year low of $0.96 and a one year high of $4.33.

Health Catalyst (NASDAQ:HCAT) last issued its quarterly earnings results on Monday, May 11th. The company reported $0.02 EPS for the quarter, beating analysts’ consensus estimates of $0.01 by $0.01. The business had revenue of $70.76 million for the quarter, compared to analysts’ expectations of $69.24 million. Health Catalyst had a negative net margin of 87.69% and a negative return on equity of 3.52%. As a group, research analysts expect that Health Catalyst, Inc. will post -0.28 EPS for the current year.

Health Catalyst Profile

Health Catalyst (NASDAQ: HCAT) is a healthcare data and analytics technology company founded in 2008 and headquartered in Salt Lake City, Utah. The company went public in 2019 and has since focused on delivering a unified data platform that helps healthcare organizations aggregate and analyze clinical, financial and operational information.

The core of Health Catalyst’s offering is the Data Operating System (DOS), a modular data management platform that integrates disparate data sources—from electronic health records to claims and patient-generated data—into a single analytics environment.